- Home
- HQL vs SPOK Comparison
HQL vs SPOK Comparison
Compare HQL & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQL
- SPOK
- Stock Information
- Founded
- HQL 1992
- SPOK 2004
- Country
- HQL United States
- SPOK United States
- Employees
- HQL N/A
- SPOK N/A
- Industry
- HQL Investment Managers
- SPOK Telecommunications Equipment
- Sector
- HQL Finance
- SPOK Telecommunications
- Exchange
- HQL Nasdaq
- SPOK Nasdaq
- Market Cap
- HQL 369.6M
- SPOK 318.9M
- IPO Year
- HQL N/A
- SPOK 1992
- Fundamental
- Price
- HQL $13.14
- SPOK $18.51
- Analyst Decision
- HQL
- SPOK Hold
- Analyst Count
- HQL 0
- SPOK 1
- Target Price
- HQL N/A
- SPOK $15.00
- AVG Volume (30 Days)
- HQL 120.9K
- SPOK 106.7K
- Earning Date
- HQL 01-01-0001
- SPOK 07-30-2025
- Dividend Yield
- HQL 11.56%
- SPOK 6.75%
- EPS Growth
- HQL N/A
- SPOK 9.25
- EPS
- HQL 0.79
- SPOK 0.83
- Revenue
- HQL N/A
- SPOK $140,742,000.00
- Revenue This Year
- HQL N/A
- SPOK $2.26
- Revenue Next Year
- HQL N/A
- SPOK $2.54
- P/E Ratio
- HQL $17.08
- SPOK $22.29
- Revenue Growth
- HQL N/A
- SPOK 1.79
- 52 Week Low
- HQL $11.34
- SPOK $13.55
- 52 Week High
- HQL $14.37
- SPOK $19.31
- Technical
- Relative Strength Index (RSI)
- HQL 51.20
- SPOK 64.56
- Support Level
- HQL $13.25
- SPOK $16.94
- Resistance Level
- HQL $13.44
- SPOK $19.31
- Average True Range (ATR)
- HQL 0.24
- SPOK 0.43
- MACD
- HQL -0.03
- SPOK 0.02
- Stochastic Oscillator
- HQL 41.54
- SPOK 66.24
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.